Evidence map›Paper›PMID 33237819›Full record

ArticleThe British journal of radiology2021

A review of staging chest CT in trunk and extremity soft tissue sarcoma.

Asif Saifuddin, Hassan Shafiq, Ramanan Rajakulasingam, Alan Tan, Paul O'Donnell, Michael Khoo

Open access · bronzeAbstract read
In one paragraph

Article in The British journal of radiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Evaluation of RECIST v1.1 for predicting overall survival in sarcoma patients with pulmonary metastasis.Cancer imaging : the official publication of the International Cancer Imaging Society · 2026
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Asif SaifuddinDepartment of Radiology, Royal National Orthopaedic Hospital, Stanmore, UK.
Hassan ShafiqDepartment of Trauma and Orthopaedics, Barts NHS Trust, London, UK.
Ramanan RajakulasingamDepartment of Radiology, Royal National Orthopaedic Hospital, Stanmore, UK.
Alan TanDepartment of Radiology, Mid and South Essex University Hospitals, Basildon, UK.
Paul O'DonnellDepartment of Radiology, Royal National Orthopaedic Hospital, Stanmore, UK.
Michael KhooDepartment of Radiology, Royal National Orthopaedic Hospital, Stanmore, UK.ORCID https://orcid.org/0000-0003-3876-2150
Royal National Orthopaedic Hospital · GBBarts Health NHS Trust · GBBasildon Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo determine the incidence of pulmonary metastases on chest CT in trunk and extremity soft tissue sarcoma based on two size criteria, and to identify factors associated with metastases.

methodsRetrospective review of chest CT studies in patients with trunk and extremity soft tissue sarcoma over an 18-month period. Data collected included patient age/sex, tumour location, size and relationship to fascia. All chest CTs were reviewed for the presence of metastases which were diagnosed according to two size criteria: multiple nodules > 5 mm in size or multiple nodules > 10 mm in size. Follow-up CT studies were reviewed in cases initially considered indeterminate.

results127 males and 73 females were included (mean age 57.1 years; range 10-90 years). 147 (73.5%) tumours were deep to the fascia and 53 (26.5%) superficial. Tumour size classified according to the 12 AJCC 2019 criteria was: T1 = 52, T2 = 76, T3 = 39, T4 = 33. Based on nodule size >5 mm, 73 (36.5%) patients had no metastases, 42 (21%) had metastases, while 85 (42.5%) studies were indeterminate. Based on nodule size >10 mm, 73 (36.5%) patients had no metastases, 28 (14%) had metastases, while 99 (49.5%) studies were indeterminate. Larger maximum dimension of the primary tumour was a risk factor for pulmonary metastases using both size criteria.

conclusionThe incidence of pulmonary metastases at presentation in trunk and extremity soft tissue sarcoma is 14-21%. 42.5-49.5% of chest CTs were indeterminate. ADVANCES IN KNOWLEDGE: The incidence of pulmonary metastases at presentation in trunk and extremity soft tissue sarcoma is 14-21%. Indeterminate pulmonary nodules are also very common.

Indexed as

AdolescentAdultAgedAged, 80 and overChildExtremitiesFemaleFollow-Up StudiesHumansLungLung NeoplasmsMaleMiddle AgedNeoplasm StagingRadiography, ThoracicRetrospective Studies

Identifiers

PMID33237819
PMCPMC7934305
OpenAlexW3110342380

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.